Effect of Aerobic Training in Patients With Oculopharyngeal Muscular Dystrophy

NCT ID: NCT02158156

Last Updated: 2014-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

8 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-02-28

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators want to investigate if patients with Oculopharyngeal Muscular Dystrophy can improve fitness by home-training on a cycle ergometer 30 minute, 3 times a week for 10 weeks.

Participants will be evaluated on maximal oxygen consumption and maximal workload measured by an incremental test at baseline and at the end of the exercise period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oculopharyngeal Muscular Dystrophy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Excercise

10 weeks of home training on a cycle-ergometer. Exercise 30 minutes every other day or at least three times a week.

Group Type EXPERIMENTAL

Exercise

Intervention Type BEHAVIORAL

Ten weeks of home-training on a cycle ergometer 3 times a week for 30 minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise

Ten weeks of home-training on a cycle ergometer 3 times a week for 30 minutes.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Danish patients with Oculopharyngeal muscular dystrophy

Exclusion Criteria

* Patients who are too week to train on an cycle-ergometer for 10 weeks
* Patients with other health issues wich confound the interpretation of the efficacy.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rigshospitalet, Denmark

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Karen Brorup Heje Pedersen

Bsc Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karen BH Pedersen, Bsc.med.

Role: PRINCIPAL_INVESTIGATOR

Neuromuscular Research Unit, Rigshospitalet, Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Neuromuscular Research Unit

Copenhagen, , Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vissing

Role: primary

+4535451842

Related Links

Access external resources that provide additional context or updates about the study.

http://www.neuromuscular.dk

Website of the Neuromuscular Research Unit, Rigshospitalet, Copenhagen, Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H2-2013-066(A)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Muscle Damage and Disuse Atrophy
NCT03559452 COMPLETED NA